Ropes & Gray Reps Axcan In $583M Eurand Deal
Pharmaceutical company Axcan Holdings Inc. announced plans Wednesday to acquire rival Eurand NV for approximately $583 million, or $12 per share....To view the full article, register now.
Already a subscriber? Click here to view full article